Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5204)
All Articles published online
|
May 21, 2005 (publication date) through Feb 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Liu P, Hu YY, Liu C, Xu LM, Liu CH, Sun KW, Hu DC, Yin YK, Zhou XQ, Wan MB, Cai X, Zhang ZQ, Ye J, Zhou RX, He J, Tang BZ. Multicenter clinical study on Fuzhenghuayu capsule against liver fibrosis due to chronic hepatitis B. World J Gastroenterol 2005; 11(19): 2892-2899 [PMID: 15902724 DOI: 10.3748/wjg.v11.i19.2892] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i19/2892.htm |
| Number | Citing Articles |
| 1 |
Zheng-xin Li, Zhi-min Zhao, Ping Liu, Qing-shan Zheng, Cheng-hai Liu. Treatment of HBV Cirrhosis with Fuzheng Huayu Tablet (扶正化瘀片) and Entecavir: Design of a Randomized, Double-Blind, Parallel and Multicenter Clinical Trial. Chinese Journal of Integrative Medicine 2021; 27(7): 509 doi: 10.1007/s11655-020-3257-6
|
| 2 |
Hongdong Xie, Yanyan Tao, Jing Lv, Ping Liu, Chenghai Liu. Proteomic Analysis of the Effect of Fuzheng Huayu Recipe on Fibrotic Liver in Rats. Evidence-Based Complementary and Alternative Medicine 2013; 2013: 1 doi: 10.1155/2013/972863
|
| 3 |
Yan-Hong Jia, Rong-Qi Wang, Hong-Mei Mi, Ling-Bo Kong, Wei-Guang Ren, Wen-Cong Li, Su-Xian Zhao, Yu-Guo Zhang, Wen-Juan Wu, Yue-Min Nan, Jun Yu. Fuzheng Huayu recipe prevents nutritional fibrosing steatohepatitis in mice. Lipids in Health and Disease 2012; 11(1) doi: 10.1186/1476-511X-11-45
|
| 4 |
Xue-mei Li, Jing-hua Peng, Zhao-lin Sun, Hua-jie Tian, Xiao-hua Duan, Lin Liu, Xin Ma, Qin Feng, Ping Liu, Yi-yang Hu. Chinese medicine CGA formula ameliorates DMN-induced liver fibrosis in rats via inhibiting MMP2/9, TIMP1/2 and the TGF-β/Smad signaling pathways. Acta Pharmacologica Sinica 2016; 37(6): 783 doi: 10.1038/aps.2016.35
|
| 5 |
Shihao Zheng, Chengyuan Xue, Size Li, Xiaobin Zao, Xiaoke Li, Qiyao Liu, Xu Cao, Wei Wang, Wenying Qi, Hongbo Du, Peng Zhang, Yongan Ye. Liver cirrhosis: current status and treatment options using western or traditional Chinese medicine. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1381476
|
| 6 |
Chia-Jung Lee, Chen-Hung Cheng, Yu-Hsien Li, Chia-Yu Liu, Chung-Hua Hsu. A Chinese Medicine, Kuan-Sin-Yin Decoction, Improves Liver Function in Hepatitis B Virus Carriers: A Randomized, Controlled Study. The Journal of Alternative and Complementary Medicine 2013; 19(12): 964 doi: 10.1089/acm.2013.0136
|
| 7 |
Hongxu Du, Jingjing Yang, Jingying Bai, Ke Ming, Jintong Shi, Fangke Yao, Wei Zhang, Yang Yu, Yun Chen, Wen Xiong, Yi Wu, Deyun Wang, Yuanliang Hu, Jiaguo Liu, Yidong Bai. A flavone-polysaccharide based prescription attenuates the mitochondrial dysfunction induced by duck hepatitis A virus type 1. PLOS ONE 2017; 12(4): e0175495 doi: 10.1371/journal.pone.0175495
|
| 8 |
Chuan Shen, Cai-Yan Zhao, Fang Liu, Ya-Dong Wang, Wei Wang. Acute Liver Failure Associated with Occupational Exposure to Tetrachloroethylene. Journal of Korean Medical Science 2011; 26(1): 138 doi: 10.3346/jkms.2011.26.1.138
|
| 9 |
Fan Cheung, Yibin Feng, Ning Wang, Man-Fung Yuen, Yao Tong, Vivian Taam Wong. Effectiveness of Chinese herbal medicine in treating liver fibrosis: a systematic review and meta-analysis of randomized controlled trials. Chinese Medicine 2012; 7(1) doi: 10.1186/1749-8546-7-5
|
| 10 |
Qilong Chen, Feizhen Wu, Mei Wang, Shu Dong, Yamin Liu, Yiyu Lu, Yanan Song, Qianmei Zhou, Ping Liu, Yunquan Luo, Shibing Su. Transcriptional Profiling and miRNA-Target Network Analysis Identify Potential Biomarkers for Efficacy Evaluation of Fuzheng-Huayu Formula-Treated Hepatitis B Caused Liver Cirrhosis. International Journal of Molecular Sciences 2016; 17(6): 883 doi: 10.3390/ijms17060883
|
| 11 |
Man Zhang, Hong-liang Liu, Kai Huang, Yuan Peng, Yan-yan Tao, Chang-qing Zhao, Xu-dong Hu, Cheng-hai Liu, Yunxia Li. Fuzheng Huayu Recipe Prevented and Treated CCl4‐Induced Mice Liver Fibrosis through Regulating Polarization and Chemotaxis of Intrahepatic Macrophages via CCL2 and CX3CL1. Evidence-Based Complementary and Alternative Medicine 2020; 2020(1) doi: 10.1155/2020/8591892
|
| 12 |
Qi Cheng, Ning Li, Mingquan Chen, Jianming Zheng, Zhiping Qian, Xinyu Wang, Chong Huang, Qian Li, Qingxia Lin, Guangfeng Shi. Fuzheng Huayu inhibits carbon tetrachloride-induced liver fibrosis in mice through activating hepatic NK cells. Journal of Ethnopharmacology 2013; 145(1): 175 doi: 10.1016/j.jep.2012.10.047
|
| 13 |
Rong Wu, Shu Dong, Fei-Fei Cai, Xiao-Le Chen, Meng-Die Yang, Ping Liu, Shi-Bing Su. Active Compounds Derived from Fuzheng Huayu Formula Protect Hepatic Parenchymal Cells from Apoptosis Based on Network Pharmacology and Transcriptomic Analysis. Molecules 2019; 24(2): 338 doi: 10.3390/molecules24020338
|
| 14 |
Zhe Ma, Bing Zhang, Yuqi Fan, Meng Wang, Dereje Kebebe, Jiawei Li, Zhidong Liu. Traditional Chinese medicine combined with hepatic targeted drug delivery systems: A new strategy for the treatment of liver diseases. Biomedicine & Pharmacotherapy 2019; 117: 109128 doi: 10.1016/j.biopha.2019.109128
|
| 15 |
Shu Dong, Fei-fei Cai, Qi-long Chen, Ya-nan Song, Yang Sun, Bin Wei, Xiao-yan Li, Yi-yang Hu, Ping Liu, Shi-bing Su. Chinese herbal formula Fuzheng Huayu alleviates CCl4-induced liver fibrosis in rats: a transcriptomic and proteomic analysis. Acta Pharmacologica Sinica 2018; 39(6): 930 doi: 10.1038/aps.2017.150
|
| 16 |
Xiaoyi Li, Lixin Zhu, Beibei Wang, Meifei Yuan, Ruixin Zhu. Drugs and Targets in Fibrosis. Frontiers in Pharmacology 2017; 8 doi: 10.3389/fphar.2017.00855
|
| 17 |
Yangyi Chen, Zhimin Zhao, Haina Fan, Zhengxin Li, Yingchun He, Chenghai Liu. Safety and therapeutic effects of anti-fibrotic Traditional Chinese Medicine Fuzheng Huayu on persistent advanced stage fibrosis following 2 years entecavir treatment: Study protocol for a single arm clinical objective performance criteria trial. Contemporary Clinical Trials Communications 2020; 19: 100601 doi: 10.1016/j.conctc.2020.100601
|
| 18 |
Hong-liang Liu, Jing Lv, Zhi-min Zhao, An-ming Xiong, Ye Tan, Jeffrey S. Glenn, Yan-yan Tao, Hong-lei Weng, Cheng-hai Liu. Fuzhenghuayu Decoction ameliorates hepatic fibrosis by attenuating experimental sinusoidal capillarization and liver angiogenesis. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-54663-4
|
| 19 |
Tao Wang, Xuelin Zhou, Honghong Liu, Jiabo Wang, Ping Zhang, Yun Zhu, Kun Li, Shizhang Wei, Haotian Li, Lifu Wang, Ruilin Wang, Yanling Zhao. Fuzheng Huayu capsule as an adjuvant treatment for HBV‐related cirrhosis: A systematic review and meta‐analysis. Phytotherapy Research 2018; 32(5): 757 doi: 10.1002/ptr.6009
|
| 20 |
Dawei Ding, Gui Jia, Lina Cui, Yansheng Liu, Xiufang Wang, Ruiqing Sun, Juan Deng, Guanya Guo, Yulong Shang, Ying Han. The prognostic value of anti-gp210 and anti-centromere antibodies in patients with primary biliary cholangitis: Enhancing the prognostic utility on the GLOBE scoring system. Digestive and Liver Disease 2025; doi: 10.1016/j.dld.2024.12.024
|
| 21 |
Chang-qing Zhao, Yang Zhou, Jian Ping, Lie-ming Xu. Traditional Chinese medicine for treatment of liver diseases: progress, challenges and opportunities. Journal of Integrative Medicine 2014; 12(5): 401 doi: 10.1016/S2095-4964(14)60039-X
|
| 22 |
Rolf Teschke, Albrecht Wolff, Christian Frenzel, Axel Eickhoff, Johannes Schulze. Herbal traditional Chinese medicine and its evidence base in gastrointestinal disorders. World Journal of Gastroenterology 2015; 21(15): 4466-4490 doi: 10.3748/wjg.v21.i15.4466
|
| 23 |
Shu Li, Lina Wang, Xiuchuan Yan, Qinglan Wang, Yanyan Tao, Junxia Li, Yuan Peng, Ping Liu, Chenghai Liu. Salvianolic Acid B Attenuates Rat Hepatic Fibrosis via Downregulating Angiotensin II Signaling. Evidence-Based Complementary and Alternative Medicine 2012; 2012: 1 doi: 10.1155/2012/160726
|
| 24 |
Detlef Schuppan. Liver fibrosis: Common mechanisms and antifibrotic therapies. Clinics and Research in Hepatology and Gastroenterology 2015; 39: S51 doi: 10.1016/j.clinre.2015.05.005
|
| 25 |
Mei Wu, Yang Zhou, Sheng-Lan Qin, Li-Jing Lin, Jian Ping, Zhang Tao, Jing Zhang, Lie-Ming Xu, Jian Wu, Ching-Liang Hsieh. Fuzheng Huayu Capsule Attenuates Hepatic Fibrosis by Inhibiting Activation of Hepatic Stellate Cells. Evidence-Based Complementary and Alternative Medicine 2020; 2020(1) doi: 10.1155/2020/3468791
|
| 26 |
Guideline for the diagnosis and treatment of liver fibrosis with integrative medicine. Journal of Chinese Integrative Medicine 2006; : 551 doi: 10.3736/jcim20060601
|
| 27 |
Qun Zhang, Yu-xin Li, Yao Liu, Yi-xin Hou, Bing-bing Zhu, Yun-yi Huang, Ke Shi, Xian-bo Wang. Effects of Adjuvant Chinese Patent Medicine Therapy on Prevention of Variceal Rebleeding: A Retrospective Cohort Study. Chinese Journal of Integrative Medicine 2021; 27(8): 589 doi: 10.1007/s11655-020-3272-7
|
| 28 |
Ralf Weiskirchen. Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step. Frontiers in Pharmacology 2016; 6 doi: 10.3389/fphar.2015.00303
|
| 29 |
Lijun Zhang, Detlef Schuppan. Traditional Chinese Medicine (TCM) for fibrotic liver disease: Hope and hype. Journal of Hepatology 2014; 61(1): 166 doi: 10.1016/j.jhep.2014.03.009
|
| 30 |
Qin Pan, Yu-Qin Wang, Guang-Ming Li, Xiao-Yan Duan, Jian-Gao Fan. Fuzheng Huayu Recipe Ameliorates Liver Fibrosis by Restoring Balance between Epithelial-to-Mesenchymal Transition and Mesenchymal-to-Epithelial Transition in Hepatic Stellate Cells. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/935903
|
| 31 |
Qi Wang, Hongbo Du, Min Li, Yue Li, Shunai Liu, Ping Gao, Xiaoli Zhang, Jun Cheng. MAPK Signal Transduction Pathway Regulation: A Novel Mechanism of Rat HSC-T6 Cell Apoptosis Induced by FUZHENGHUAYU Tablet. Evidence-Based Complementary and Alternative Medicine 2013; 2013: 1 doi: 10.1155/2013/368103
|
| 32 |
Yanuo Li, Yan Shi, Yan Sun, Luying Liu, Xianyong Bai, Dong Wang, Hongxing Li. Restorative effects of hydroxysafflor yellow A on hepatic function in an experimental regression model of hepatic fibrosis induced by carbon tetrachloride. Molecular Medicine Reports 2017; 15(1): 47 doi: 10.3892/mmr.2016.5965
|
| 33 |
Shu Dong, Qi-Long Chen, Shi-Bing Su. Curative Effects of Fuzheng Huayu on Liver Fibrosis and Cirrhosis: A Meta-Analysis. Evidence-Based Complementary and Alternative Medicine 2015; 2015: 1 doi: 10.1155/2015/125659
|
| 34 |
Dawei Ding, Yinan Hu, Gui Jia, Boling Wang, Linhua Zheng, Juan Deng, Ruiqing Sun, Xiufang Wang, Guanya Guo, Lina Cui, Yulong Shang, Ying Han. Low-risk individuals with primary biliary cholangitis and significant liver stiffness: prognosis and treatment. Hepatology International 2024; doi: 10.1007/s12072-024-10743-w
|
| 35 |
Dabing Ping, Jingshu Qi, Meng Li, Xin Sun, Yuan Peng, Chenghai Liu. Fuzheng Huayu recipe alleviates liver fibrosis via inhibiting NLRP3 inflammasome activation in macrophages. Journal of Ethnopharmacology 2024; 318: 117001 doi: 10.1016/j.jep.2023.117001
|
| 36 |
Ye Luo, Xu Zhao, Ruilin Wang, Xiaoyan Zhan, Tianyi Zhang, Tingting He, Jing Jing, Jianyu Li, Fengyi Li, Ping Zhang, Junling Cao, Jinfa Tang, Zhijie Ma, Tingming Shen, Shuanglin Qin, Ming Yang, Jun Zhao, Zhaofang Bai, Jiabo Wang, Aiguo Dai, Xiangmei Chen, Xiaohe Xiao. Integrated evidence chain-based effectiveness evaluation of traditional Chinese medicines (Eff-iEC): A demonstration study. Acta Pharmaceutica Sinica B 2024; doi: 10.1016/j.apsb.2024.12.024
|
| 37 |
Shiyu Ma, Lan Shen, Yu Zhai, Xiao Lin, Yi Feng, Lieming Xu, Kefeng Ruan. An integral evaluation method for synchronous drug release based on a mathematics set in guiding the preparation of multi-component traditional Chinese medicine. Anal. Methods 2014; 6(7): 2260 doi: 10.1039/C3AY41850B
|
| 38 |
Yi-Qi Liu, Chi Zhang, Jia-Wen Li, Li-Hua Cao, Zhan-Qing Zhang, Wei-Feng Zhao, Qing-Hua Shang, Da-Zhi Zhang, An-Lin Ma, Qing Xie, Hong-Lian Gui, Guo Zhang, Ying-Xia Liu, Jia Shang, Shi-Bin Xie, Jun Li, Xu-Qing Zhang, Zhi-Qiang Zou, Yu-Ping Chen, Zong Zhang, Ming-Xiang Zhang, Jun Cheng, Fu-Chun Zhang, Li-Hua Huang, Jia-Bin Li, Qing-Hua Meng, Hai-Bin Yu, Yu-Qiang Mi, Yan-Zhong Peng, Zhi-Jin Wang, Li-Ming Chen, Fan-Ping Meng, Wan-Hua Ren, Lang Bai, Yi-Lan Zeng, Rong Fan, Xian-Zhi Lou, Wei-Feng Liang, Hui Liu, Hui Zhuang, Hong Zhao, Guiqiang Wang. An-Luo-Hua-Xian Pill Can Improve the Regression of Liver Fibrosis in Chronic Hepatitis B Patients Treated With Entecavir. SSRN Electronic Journal 2021; doi: 10.2139/ssrn.3960667
|
| 39 |
Dan-Ying Cheng, Zhi-Min Zhao, Gang Wan, Huan-Wei Zheng, Jia-Quan Huang, Cheng-Hai Liu, Hui-Chun Xing. Impact of Fuzheng Huayu tablet on antiviral effect of entecavir in patients with hepatitis B cirrhosis. Hepatobiliary & Pancreatic Diseases International 2022; 21(5): 479 doi: 10.1016/j.hbpd.2022.03.007
|
| 40 |
Hui Li. Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula. Journal of Ethnopharmacology 2020; 251: 112442 doi: 10.1016/j.jep.2019.112442
|
| 41 |
Jie Gu, Qin Zhang, Dongying Xue, Hong Cai, Lieming Xu. A Randomized Controlled Study of Fuzheng Huayu Capsule for Prevention of Esophageal Variceal Bleeding in Patients with Liver Cirrhosis. Evidence-Based Complementary and Alternative Medicine 2013; 2013: 1 doi: 10.1155/2013/534960
|
| 42 |
Xin Sun, Ye Tan, Jing Lyu, Hong-liang Liu, Zhi-min Zhao, Cheng-hai Liu. Active Components Formulation Developed from Fuzheng Huayu Recipe for Anti-Liver Fibrosis. Chinese Journal of Integrative Medicine 2022; 28(6): 538 doi: 10.1007/s11655-021-3293-x
|
| 43 |
Yuewen Gong. Identifying the targets for treatment of liver fibrosis and hepatocellular carcinoma from both Western medicine and Chinese medicine. Chinese Journal of Integrative Medicine 2012; 18(4): 245 doi: 10.1007/s11655-012-1062-6
|
| 44 |
Yun-Kai Dai, Zhi-Min Zhao, Chenghai Liu. Treatment of Liver Fibrosis: A 20-Year Bibliometric and Knowledge-Map Analysis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.942841
|
| 45 |
Hong-lian Gui, Chang-qing Zhao, Yan Wang, Hong-tu Gu, Wei-jing Wang, Wei Cai, Qing Guo, Shi-san Bao, Lie-ming Xu, Qing Xie. Histological Outcome of Fuzheng Huayu plus Entecavir Combination Therapy in Chronic Hepatitis B Patients with Significant Liver Fibrosis. Journal of Clinical and Translational Hepatology 2020; 8(3): 1 doi: 10.14218/JCTH.2020.00004
|
| 46 |
Huajie Tian, Lin Liu, Zhixiong Li, Wei Liu, Zhaolin Sun, Yongbin Xu, Shunchun Wang, Chungeng Liang, Yamei Hai, Qin Feng, Yu Zhao, Yiyang Hu, Jinghua Peng. Chinese medicine CGA formula ameliorates liver fibrosis induced by carbon tetrachloride involving inhibition of hepatic apoptosis in rats. Journal of Ethnopharmacology 2019; 232: 227 doi: 10.1016/j.jep.2018.11.027
|
| 47 |
Zhi-Jun Hou, Jing-Hao Zhang, Xin Zhang, Qi-Hua Ling, Chao Zheng, Xiao-Jun Zhu, Zhen-Hua Zhou, Man Li, Xiao-Ni Kong, Xue-Hua Sun, Yue-Qiu Gao, Jian-Jie Chen, Maria G. Miguel. Long‐Term Traditional Chinese Medicine Combined with NA Antiviral Therapy on Cirrhosis Incidence in Chronic Hepatitis B Patients in the Real‐World Setting: A Retrospective Study. Evidence-Based Complementary and Alternative Medicine 2020; 2020(1) doi: 10.1155/2020/3826857
|
| 48 |
Niantong Xia, Zimian Ding, Mingran Dong, Shuyang Li, Jia Liu, Hongwei Xue, Zhigang Wang, Juan Lu, Xi Chen. Protective Effects of Lycium ruthenicum Murray against Acute Alcoholic Liver Disease in Mice via the Nrf2/HO-1/NF-κB Signaling Pathway. Pharmaceuticals 2024; 17(4): 497 doi: 10.3390/ph17040497
|
| 49 |
Christian Trautwein, Scott L. Friedman, Detlef Schuppan, Massimo Pinzani. Hepatic fibrosis: Concept to treatment. Journal of Hepatology 2015; 62(1): S15 doi: 10.1016/j.jhep.2015.02.039
|
| 50 |
Ping Liu. Fuzheng Huayu Capsule (扶正化瘀胶囊) in the treatment of liver fibrosis: Clinical evidence and mechanism of action. Chinese Journal of Integrative Medicine 2012; 18(5): 398 doi: 10.1007/s11655-012-1030-1
|
| 51 |
Shao-Ru Chen, Xiu-Ping Chen, Jin-Jian Lu, Ying Wang, Yi-Tao Wang. Potent natural products and herbal medicines for treating liver fibrosis. Chinese Medicine 2015; 10(1) doi: 10.1186/s13020-015-0036-y
|
| 52 |
Shujun Sun, Jianye Dai, Wenyu Wang, Huijuan Cao, Junwei Fang, Yi Yang Hu, Shibing Su, Yongyu Zhang. Metabonomic Evaluation of ZHENG Differentiation and Treatment by Fuzhenghuayu Tablet in Hepatitis-B-Caused Cirrhosis. Evidence-Based Complementary and Alternative Medicine 2012; 2012: 1 doi: 10.1155/2012/453503
|
| 53 |
Ming Hong, Sha Li, Hor Tan, Ning Wang, Sai-Wah Tsao, Yibin Feng. Current Status of Herbal Medicines in Chronic Liver Disease Therapy: The Biological Effects, Molecular Targets and Future Prospects. International Journal of Molecular Sciences 2015; 16(12): 28705 doi: 10.3390/ijms161226126
|
| 54 |
Ting-Ting Jiang, Xiao-Li Liu, Yu-Yong Jiang, Xian-Bo Wang, Zhi-Yun Yang, Guang Chen. Minimal Hepatic Encephalopathy and Biejia-Ruangan Are Associated with First Hospital Readmission in Nonalcoholic Cirrhosis Patients. Evidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/6652858
|
| 55 |
Jingshu Qi, Dabing Ping, Xin Sun, Kai Huang, Yuan Peng, Chenghai Liu. A herbal product inhibits carbon tetrachloride-induced liver fibrosis by suppressing the epidermal growth factor receptor signaling pathway. Journal of Ethnopharmacology 2023; 311: 116419 doi: 10.1016/j.jep.2023.116419
|
| 56 |
Tarek Hassanein, Dean Tai, Chenghai Liu, Terry D. Box, Myron J. Tong, Lorenzo Rossaro, Renee Pozza, Jeffrey S. Glenn, Ramsey Cheung, Ammar Hemaidan, Yingchun He, Cynthia Behling, Xiqi Hu, Hala Makhlouf, Haina Fan, Yayun Ren, Elaine Lay Khim Chng, Ping Liu, John M. Vierling, Jian-You Guo. Efficacy and Safety of a Botanical Formula Fuzheng Huayu for Hepatic Fibrosis in Patients with CHC: Results of a Phase 2 Clinical Trial. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/4494099
|
| 57 |
Yan-fang Deng, Qian-qian Xu, Tian-qi Chen, Jia-xiong Ming, Ya-fen Wang, Li-na Mao, Jia-jun Zhou, Wei-guang Sun, Qun Zhou, Hong Ren, Yong-hui Zhang. Kinsenoside alleviates inflammation and fibrosis in experimental NASH mice by suppressing the NF-κB/NLRP3 signaling pathway. Phytomedicine 2022; 104: 154241 doi: 10.1016/j.phymed.2022.154241
|
| 58 |
Yibin Feng, Kwok-Fan Cheung, Ning Wang, Ping Liu, Tadashi Nagamatsu, Yao Tong. Chinese medicines as a resource for liver fibrosis treatment. Chinese Medicine 2009; 4(1) doi: 10.1186/1749-8546-4-16
|
| 59 |
Chun-Hui Li, Li-Hui Pan, Zong-Wei Yang, Chun-Yu Li, Wen-Xie Xu. Preventive effect of <italic>Qianggan-Rongxian</italic> Decoction on rat liver fibrosis. World Journal of Gastroenterology 2008; 14(22): 3569-3573 doi: 10.3748/wjg.14.3569
|
| 60 |
Jiamei Chen, Yonghong Hu, Long Chen, Wei Liu, Yongping Mu, Ping Liu. The effect and mechanisms of Fuzheng Huayu formula against chronic liver diseases. Biomedicine & Pharmacotherapy 2019; 114: 108846 doi: 10.1016/j.biopha.2019.108846
|
| 61 |
Zhi-Min Zhao, Chuan-Wu Zhu, Jia-Quan Huang, Xiao-Dong Li, Yu-Xi Zhang, Jian Liang, Wei Zhang, Yong Zhang, Xian-Gao Jiang, Ya-Li Zong, Ke-Jun Zhang, Ke-Wei Sun, Biao Zhang, Yun-Hai Lv, Hui-Chun Xing, Qing Xie, Ping Liu, Cheng-Hai Liu. Efficacy and safety of Fuzheng Huayu tablet on persistent advanced liver fibrosis following 2 years entecavir treatment: A single arm clinical objective performance criteria trial. Journal of Ethnopharmacology 2022; 298: 115599 doi: 10.1016/j.jep.2022.115599
|
| 62 |
Wei Liu, Zhixiong Li, Zhaolin Sun, Yongbin Xu, Shunchun Wang, Yiyang Hu, Jinghua Peng. The components data of fuzheng huayu extracts, cordyceps sinensis mycelia polysaccharide, gypenosides and amygdalin. Data in Brief 2019; 25: 104087 doi: 10.1016/j.dib.2019.104087
|
| 63 |
Jiamei Chen, Wei Gao, Ping Zhou, Xiaocui Ma, Benjamin Tschudy-Seney, Chenghai Liu, Mark A Zern, Ping Liu, Yuyou Duan. Enhancement of hepatocyte differentiation from human embryonic stem cells by Chinese medicine Fuzhenghuayu. Scientific Reports 2016; 6(1) doi: 10.1038/srep18841
|
| 64 |
Xin Sun, Tao Yang, Chunwu Zhu, Hainan Wang, Chenghai Liu. Herbal Medicine-Induced Liver Injury in China. Integrative Medicine International 2016; 3(1-2): 53 doi: 10.1159/000444485
|